OXT and obesity due to melanocortin 4 receptor deficiency: Our previous study using mouse models had shown that enhancing the intra-brain action of OXT can prevent against the development of obesity and obesity-related diabetic symptoms such as insulin resistance, glucose intolerance, pancreatic islet hypertrophy and steatosis against dietary overnutrition [14].